Domain created to manage non eCTD4 controlled vocabularies required to support IDMP
|
HA Controlled Vocabulary
Controlled Vocabulary / Code System Name as defoined by the Health Authority
|
Term
Term Description as defined by the Health Authority
|
Code
Code, if any, associated with the term by the Health Authority
|
Agency
Name of the issuing Health Authority (abbreviation) that maintains the term and code
|
Status
Current status of the Term usage as defined by the Health Authority (e.g., Current, Retired, Deprecated)
|
|---|---|---|---|---|
| SPL Drug Route of Administration Terminology | PERCUTANEOUS |
C38676
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | PENDANT |
C87542
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | PELLETS, COATED, EXTENDED RELEASE |
C42918
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | PELLET, IMPLANTABLE |
C42943
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | PELLET |
C42969
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED |
C42911
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | PATCH, EXTENDED RELEASE |
C42923
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | PATCH |
C42968
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | PASTILLE |
C60985
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | PASTE, DENTIFRICE |
C42907
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | PASTE |
C42967
|
FDA | — |
| SPL Business Operation Terminology | PARTICLE SIZE REDUCTION |
C84386
|
FDA | — |
| SPL Drug Route of Administration Terminology | PARENTERAL |
C38291
|
FDA | — |
| SPL Business Operation Terminology | PACK |
C84731
|
FDA | — |
| SPL Business Operation Terminology | OUTSOURCING HUMAN DRUG COMPOUNDING |
C82434
|
FDA | — |
| SPL Marketing Category Terminology | Outsourcing Facility Compounded Human Drug Product (Not Marketed - Not Distributed) |
C190698
|
FDA | — |
| SPL Marketing Category Terminology | Outsourcing Facility Compounded Human Drug Product (Exempt From Approval Requirements) |
C181659
|
FDA | — |
| SPL Business Operation Terminology | Outsourcing Animal Drug Compounding |
C122061
|
FDA | — |
| SPL Drug Route of Administration Terminology | OTHER |
C38290
|
FDA | — |
| SPL Marketing Category Terminology | OTC Monograph Drug Product Manufactured Under Contract |
C132334
|
FDA | — |
| SPL Marketing Category Terminology | OTC MONOGRAPH DRUG PRODUCT MANUFACTURED EXCLUSIVELY FOR PRIVATE LABEL DISTRIBUTOR |
C95601
|
FDA | — |
| SPL Marketing Category Terminology | OTC Monograph Drug |
C200263
|
FDA | — |
| SPL Drug Route of Administration Terminology | OROPHARYNGEAL |
C38289
|
FDA | — |
| SPL Drug Route of Administration Terminology | ORAL |
C38288
|
FDA | — |
| SPL Drug Route of Administration Terminology | OPHTHALMIC |
C38287
|
FDA | — |
Showing 126–150 of 401 terms . Data sourced from public health authority publications and updated periodically.